Health-related quality of life for normal glycaemia, prediabetes and type 2 diabetes mellitus:Cross-sectional analysis of the ADDITION-PRO study

Uloženo v:
Podrobná bibliografie
Název: Health-related quality of life for normal glycaemia, prediabetes and type 2 diabetes mellitus:Cross-sectional analysis of the ADDITION-PRO study
Autoři: Leal, Jose, Becker, Frauke, Feenstra, Talitha, Pagano, Eva, Jensen, Troels Mygind, Vistisen, Dorte, Witte, Daniel R., Jorgensen, Marit Eika
Zdroj: Leal, J, Becker, F, Feenstra, T, Pagano, E, Jensen, T M, Vistisen, D, Witte, D R & Jorgensen, M E 2022, 'Health-related quality of life for normal glycaemia, prediabetes and type 2 diabetes mellitus : Cross-sectional analysis of the ADDITION-PRO study', Diabetic Medicine, vol. 39, no. 6, e14825. https://doi.org/10.1111/dme.14825
Rok vydání: 2022
Sbírka: University of Southern Denmark: Research Output / Syddansk Universitet
Témata: EQ-5D utility, health-related quality of life, prediabetes, Cross-Sectional Studies, Humans, Quality of Life, Surveys and Questionnaires, Glucose, Health Status, Diabetes Mellitus, Type 2/epidemiology, Prediabetic State/epidemiology
Popis: Aims: We estimated and compared health-related quality of life for individuals with normal glucose tolerance, prediabetes and diabetes. Methods: Participants in the ADDITION-PRO study, Denmark, who attended a health assessment between 2009 and 2011, and who completed the 3-level EuroQoL 5-dimensions (EQ-5D-3L) questionnaire were included. For the present study, they were classified as normal glucose tolerance, prediabetes and diabetes (screen-detected and known) using the 2019 American Diabetes Association criteria. Prediabetes was defined as impaired fasting glucose, impaired glucose tolerance or HbA1c between 5.7–6.4% (39–47 mmol/mol). EQ-5D-3L data were converted into utility scores using Danish and UK values, where ‘1’ equals full health and ‘0’ equals death. Regression models estimated the association between utility and the different glucose health states. Results: The mean EQ-5D-3L score in the sample population was 0.86 ± 0.17 (median 0.85, interquartile range 0.76 to 1) using UK values. Almost half of the sample (48%) reported full health with an EQ-5D score of ‘1’. Individuals with known diabetes reported the lowest EQ-5D-3L utility scores (0.81 ± 0.20), followed by individuals with screen-detected diabetes (0.85 ± 0.19), prediabetes (0.86 ± 0.17) and normal glucose tolerance (0.90 ± 0.15). The differences were statistically significant for normal glucose and known diabetes relative to prediabetes, after adjusting for sex, age, smoking, BMI and physical activity. These findings also held using Danish values albeit the differences were of smaller magnitude. Conclusions: Having prediabetes and diabetes was significantly associated with lower health-related quality of life relative to normal glucose tolerance. Our estimates will be useful to inform the value of interventions to prevent diabetes or prediabetes.
Druh dokumentu: article in journal/newspaper
Popis souboru: application/pdf
Jazyk: English
DOI: 10.1111/dme.14825
Dostupnost: https://portal.findresearcher.sdu.dk/da/publications/5ab88ab3-2229-4b9c-bc06-8fd963d46ce6
https://doi.org/10.1111/dme.14825
https://findresearcher.sdu.dk/ws/files/207510091/Diabetic_Medicine_2022_Leal_Health_related_quality_of_life_for_normal_glycaemia_prediabetes_and_type_2_diabetes.pdf
Rights: info:eu-repo/semantics/openAccess
Přístupové číslo: edsbas.B8218950
Databáze: BASE
Popis
Abstrakt:Aims: We estimated and compared health-related quality of life for individuals with normal glucose tolerance, prediabetes and diabetes. Methods: Participants in the ADDITION-PRO study, Denmark, who attended a health assessment between 2009 and 2011, and who completed the 3-level EuroQoL 5-dimensions (EQ-5D-3L) questionnaire were included. For the present study, they were classified as normal glucose tolerance, prediabetes and diabetes (screen-detected and known) using the 2019 American Diabetes Association criteria. Prediabetes was defined as impaired fasting glucose, impaired glucose tolerance or HbA1c between 5.7–6.4% (39–47 mmol/mol). EQ-5D-3L data were converted into utility scores using Danish and UK values, where ‘1’ equals full health and ‘0’ equals death. Regression models estimated the association between utility and the different glucose health states. Results: The mean EQ-5D-3L score in the sample population was 0.86 ± 0.17 (median 0.85, interquartile range 0.76 to 1) using UK values. Almost half of the sample (48%) reported full health with an EQ-5D score of ‘1’. Individuals with known diabetes reported the lowest EQ-5D-3L utility scores (0.81 ± 0.20), followed by individuals with screen-detected diabetes (0.85 ± 0.19), prediabetes (0.86 ± 0.17) and normal glucose tolerance (0.90 ± 0.15). The differences were statistically significant for normal glucose and known diabetes relative to prediabetes, after adjusting for sex, age, smoking, BMI and physical activity. These findings also held using Danish values albeit the differences were of smaller magnitude. Conclusions: Having prediabetes and diabetes was significantly associated with lower health-related quality of life relative to normal glucose tolerance. Our estimates will be useful to inform the value of interventions to prevent diabetes or prediabetes.
DOI:10.1111/dme.14825